TSHA Taysha Gene Therapies, Inc.
Healthcare$5.49-0.90%ClosedMarket Cap: $1.37B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$11.50
Target (Median)
$11.00
Target Range
$11.00 - $13.00
Upside from current price: 109.5%
Rating Distribution
3 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-19 | Needham | maintain | Buy | Buy |
| 2026-03-19 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-06 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-05 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-05 | Chardan Capital | maintain | Buy | Buy |
| 2025-11-05 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-10-17 | Needham | maintain | Buy | Buy |
| 2025-10-02 | Baird | maintain | Outperform | Outperform |
| 2025-08-13 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.32 | $38.9M | 6 |
| Sun Dec 31 | $-0.26 | $150.2M | 6 |
| Mon Dec 31 | $0.23 | $479.5M | 4 |
| Tue Dec 31 | $1.00 | $957.9M | 2 |